Phibro Animal Health Corporation (PAHC) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Phibro Animal Health Corp...

    NASDAQ: PAHC · Real-Time Price · USD
    39.45
    0.38 (0.97%)
    At close: Sep 05, 2025, 3:59 PM
    39.45
    0.00%
    After-hours: Sep 05, 2025, 05:34 PM EDT

    Phibro Animal Health Income Statement

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2025 FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2025 Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    Revenue
    		 1.3B 1.02B 977.89M 942.3M 833.35M
    Cost of Revenue
    		 896.27M 704.59M 679.65M 656.9M 561.97M
    Gross Profit
    		 399.94M 313.09M 298.24M 285.4M 271.38M
    Operating Income
    		 110.47M 53.31M 71.85M 46.3M 75.96M
    Interest Income
    		 n/a 4.47M 3.35M 816K 838K
    Pretax Income
    		 67.99M 10.92M 54.07M 72.3M 66.47M
    Net Income
    		 48.26M 2.42M 32.61M 49.17M 54.38M
    Selling & General & Admin
    		 289.48M 217.89M 195.1M 206.4M 178.75M
    Research & Development
    		 n/a 29.19M 24.39M 20.83M 17.76M
    Other Expenses
    		 n/a n/a n/a n/a n/a
    Operating Expenses
    		 289.48M 260.3M 226.39M 206.4M 196.51M
    Interest Expense
    		 34.6M 37.51M 28.55M 9.79M 10.4M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a
    Cost & Expenses
    		 1.19B 964.36M 906.04M 863.3M 758.48M
    Income Tax Expense
    		 19.73M 8.5M 21.46M 23.2M 12.08M
    Shares Outstanding (Basic)
    		 n/a 40.5M 40.5M 40.5M 40.47M
    Shares Outstanding (Diluted)
    		 n/a 40.52M 40.5M 40.5M 40.5M
    EPS (Basic)
    		 1.19 0.06 0.81 1.21 1.34
    EPS (Diluted)
    		 1.19 0.06 0.81 1.21 1.34
    EBITDA
    		 148.2M 84.61M 106.03M 114.82M 105.5M
    EBIT
    		 n/a 32.89M 72.02M 84.43M 78.33M
    Depreciation & Amortization
    		 45.6M 36.18M 34.01M 32.7M 31.88M

    Add to Watchlist